Weiss Asset Management LP[1 »

Halozyme Therapeutics shares owned by Weiss Asset Management LP[1

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Weiss Asset Management LP[1 from 13F filings

Historical chart of Weiss Asset Management LP[1 investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Weiss Asset Management LP[1 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Weiss Asset Management LP[1

Quarter filed Position value Share count Share price at filing
2025-09-30 $397k 5.4k 73.34
2025-06-30 $11M 211k 52.02
2018-09-30 $378k 21k 18.16
2018-06-30 $351k 21k 16.86
2018-03-31 $408k 21k 19.60
2017-12-31 $422k 21k 20.27

More positions owned by Weiss Asset Management LP[1

Strategy Cl A New (MSTR)
NVIDIA Corporation Put Option (NVDA)
Ishares Bitcoin Trust Etf Shs Ben Int Put Option (IBIT)
Ishares Ethereum Tr SHS Put Option (ETHA)
Interdigital Note 3.500% 6/0 (Principal)
Tesla Motors (TSLA)
Coinbase Global Com Cl A (COIN)
Strategy Note 0.625% 9/1 (Principal)
Super Micro Computer Note 3.500% 3/0 (Principal)
Ionis Pharmaceuticals Note 4/0 (Principal)
Theravance Biopharma (TBPH)
Sunrun Note 4.000% 3/0 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Circle Internet Group Com Cl A (CRCL)
Broadcom Put Option (AVGO)

View all positions for Weiss Asset Management LP[1

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Arrowstreet Capital, Limited Partnership
Invesco
UBS Group
Snyder Capital Management
D. E. Shaw & Co
Geode Capital Management
Dimensional Fund Advisors
Alliancebernstein
Morgan Stanley
Macquarie Group
Federated Investors
Congress Asset Management

View all funds holding Halozyme Therapeutics